New products
BD reports nine-month AGILITY trial data for Revello stent
BD announced nine-month clinical data from the AGILITY Investigational Device Exemption trial evaluating its Revello Vascular Covered Stent in the iliac vascular segment. The trial is part of BD's regulatory pathway for the device, which is designed for treatment of iliac arterial disease.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network